Balkan Bedih, Kaya Ebru, Gokoglu Gökçe, Balkan Ali Osman, Yilmaz Gülseren
Department of Adult Intensive Care, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, TUR.
Department of Intensive Care Unit, Kanuni Sultan Suleyman Training and Research Hospital, İstanbul, TUR.
Cureus. 2025 May 24;17(5):e84717. doi: 10.7759/cureus.84717. eCollection 2025 May.
Hypercarbic respiratory failure due to chronic lung disease is common and presents significant challenges, especially as many patients have multiple comorbidities. Chronic obstructive pulmonary disease (COPD) is one of the leading causes. Patients with COPD and respiratory failure, whether acute or chronic, face worse prognoses. Managing exacerbations of chronic obstructive pulmonary disease (COPD) requires a personalized approach, taking into account the patient's specific clinical profile and comorbid conditions. High-flow nasal cannula (HFNC) therapy has been shown to prevent the need for intubation and may aid in the early extubation process. In patients with COPD who develop hypercapnic respiratory failure while in the intensive care unit (ICU), the decision between high-flow nasal oxygen (HFNO), noninvasive ventilation (NIV), and invasive mechanical ventilation should be made based on the severity of respiratory failure, the patient's overall health status, and individual characteristics. The selection of the appropriate ventilatory support method must also consider factors such as the degree of respiratory distress, blood gas abnormalities, and the presence of other underlying medical conditions that could influence the response to treatment. Each intervention has its indications, benefits, and limitations, and the optimal choice should be tailored to the patient's needs. Noninvasive ventilation (NIMV) has become this population's primary respiratory support method, though comfort issues can hamper patient compliance. High-flow nasal oxygen (HFNO) devices have emerged as a valuable alternative. This study presents cases illustrating the application of conventional NIMV, HFNO, and invasive ventilation in treating hypercarbic respiratory failure. Written consent was obtained from the patient's relatives for all procedures to be performed on all three patients after admission to the intensive care unit.
慢性肺病所致的高碳酸血症性呼吸衰竭很常见,且带来重大挑战,尤其是许多患者有多种合并症。慢性阻塞性肺疾病(COPD)是主要病因之一。患有COPD和呼吸衰竭的患者,无论急性还是慢性,预后都较差。处理慢性阻塞性肺疾病(COPD)急性加重需要个性化方法,要考虑患者的具体临床特征和合并症。高流量鼻导管(HFNC)治疗已被证明可避免插管需求,并可能有助于早期拔管过程。在重症监护病房(ICU)中发生高碳酸血症性呼吸衰竭的COPD患者中,应根据呼吸衰竭的严重程度、患者的整体健康状况和个体特征,在高流量鼻氧(HFNO)、无创通气(NIV)和有创机械通气之间做出选择。选择合适的通气支持方法还必须考虑呼吸窘迫程度、血气异常以及可能影响治疗反应的其他基础疾病等因素。每种干预措施都有其适应证、益处和局限性,最佳选择应根据患者需求进行调整。无创通气(NIMV)已成为该人群的主要呼吸支持方法,不过舒适度问题可能会妨碍患者依从性。高流量鼻氧(HFNO)设备已成为一种有价值的替代方法。本研究介绍了一些病例,说明传统NIMV、HFNO和有创通气在治疗高碳酸血症性呼吸衰竭中的应用。在三名患者入住重症监护病房后,已获得患者亲属对所有拟对这三名患者进行的操作的书面同意。